beta-solamarine has been researched along with u 0126 in 1 studies
Studies (beta-solamarine) | Trials (beta-solamarine) | Recent Studies (post-2010) (beta-solamarine) | Studies (u 0126) | Trials (u 0126) | Recent Studies (post-2010) (u 0126) |
---|---|---|---|---|---|
63 | 2 | 38 | 2,816 | 2 | 1,213 |
Protein | Taxonomy | beta-solamarine (IC50) | u 0126 (IC50) |
---|---|---|---|
RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | 0.29 | |
Serine/threonine-protein kinase B-raf | Homo sapiens (human) | 0.25 | |
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.07 | |
Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | 0.2816 | |
Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | 0.2529 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ao, S; Dong, B; Du, H; Fu, R; Hu, Y; Ji, J; Lv, G; Sun, Z; Wang, X; Zhang, L | 1 |
1 other study(ies) available for beta-solamarine and u 0126
Article | Year |
---|---|
Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway.
Topics: Animals; Butadienes; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mice; Nitriles; RNA, Long Noncoding; Solanaceous Alkaloids; Stomach Neoplasms; Up-Regulation; Xenograft Model Antitumor Assays | 2019 |